ZA731012B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA731012B ZA731012B ZA731012A ZA731012A ZA731012B ZA 731012 B ZA731012 B ZA 731012B ZA 731012 A ZA731012 A ZA 731012A ZA 731012 A ZA731012 A ZA 731012A ZA 731012 B ZA731012 B ZA 731012B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2207860A DE2207860A1 (de) | 1972-02-19 | 1972-02-19 | Arzneimittel, insbesondere fuer die durchblutung des gehirns, verfahren zur herstellung von dafuer geeigneten wirkstoffen und diese wirkstoffe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA731012B true ZA731012B (en) | 1974-05-29 |
Family
ID=5836461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA731012A ZA731012B (en) | 1972-02-19 | 1973-02-13 | Pharmaceutical compositions |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE795345A (de) |
| DE (1) | DE2207860A1 (de) |
| ZA (1) | ZA731012B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2432702C2 (de) * | 1974-07-08 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von Hydroxyalkylxanthinen |
| DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
| EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
| US5473070A (en) * | 1992-11-16 | 1995-12-05 | Cell Therapeutics, Inc. | Substituted long chain alcohol xanthine compounds |
| AU1090795A (en) * | 1993-11-12 | 1995-05-29 | Cell Therapeutics, Inc. | Method for preventing tissue injury from hypoxia |
-
0
- BE BE795345D patent/BE795345A/xx not_active IP Right Cessation
-
1972
- 1972-02-19 DE DE2207860A patent/DE2207860A1/de not_active Withdrawn
-
1973
- 1973-02-13 ZA ZA731012A patent/ZA731012B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE795345A (fr) | 1973-08-13 |
| DE2207860A1 (de) | 1973-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA731808B (en) | Pharmaceutical compositions | |
| HK41078A (en) | Pharmaceutical composition | |
| ZA733406B (en) | Pharmaceutical formulations | |
| AU6069773A (en) | Compositions | |
| IL43766A0 (en) | Pharmaceutical compositions containing bis-phenolalkane derivatives | |
| AU475599B2 (en) | Pharmaceutical compositions | |
| AU5731773A (en) | 2-oxo-indoline compounds and pharmaceutical compositions | |
| ZA731012B (en) | Pharmaceutical compositions | |
| ZA732439B (en) | Pharmaceutical composition | |
| IL41564A0 (en) | Pharmaceutical compositions containing n-cyclohexyl-benzylamine derivatives | |
| ZA738489B (en) | Pharmaceutical formulations | |
| ZA734331B (en) | Pharmaceutical compositions | |
| AU5915973A (en) | Pharmaceutical compositions | |
| ZA735524B (en) | Therapeutic compositions | |
| AU471794B2 (en) | Iodophor-steroid pharmaceutical compositions | |
| CA1006816A (fr) | Compositions pharmaceutiques | |
| AU5207873A (en) | Pharmaceutical compositions | |
| MY7900236A (en) | Pharmaceutical wypolipidemic compositions | |
| ZA735099B (en) | Pharmaceutical composition | |
| AU6063773A (en) | Pharmaceutical compositions | |
| CA907516A (en) | Pharmaceutical compositions | |
| CA892542A (en) | Pharmaceutical compositions | |
| CA896528A (en) | Pharmaceutical compositions | |
| CA899777A (en) | Pharmaceutical compositions | |
| CA900356A (en) | Pharmaceutical compositions |